What does CUSIP 05464T104 represent in this 13F holders report?

CUSIP 05464T104 is the security identifier for AXSM - Axsome Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AXSM - Axsome Therapeutics, Inc. - Common Stock in Q1 2021?

181 institutional investors reported AXSM - Axsome Therapeutics, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 48,932,355
Total 13F shares: 22,937,308
Share change: -983,129
Total reported value: $1,299,681,826
Put/Call ratio: 370%
Price per share: $56.62
Number of holders: 181
Value change: -$60,738,349
Number of buys: 94
Number of sells: 78

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 05464T104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	5.4%	2,641,074	$215,167,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	4.7%	2,279,766	$185,733,000	—	31 Dec 2020	13F
IRIDIAN ASSET MANAGEMENT LLC/CT	13F	Company	4.2%	2,064,158	$168,167,000	—	31 Dec 2020	13F
RTW INVESTMENTS, LP	13F	Company	3.4%	1,672,416	$136,252,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.4%	1,655,447	$134,869,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.1%	1,039,255	$84,668,000	—	31 Dec 2020	13F
ALETHEA CAPITAL MANAGEMENT, LLC	13F	Company	2.1%	1,009,799	$82,268,000	—	31 Dec 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	1.7%	856,236	$69,758,000	—	31 Dec 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	1.6%	778,834	$63,452,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	1.5%	724,139	$58,996,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	1.3%	643,617	$52,435,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.2%	597,798	$48,703,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	1%	507,183	$41,320,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.92%	448,653	$36,552,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.87%	427,301	$34,812,000	—	31 Dec 2020	13F
STIFEL FINANCIAL CORP	13F	Company	0.83%	406,030	$33,079,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.82%	399,092	$32,514,000	—	31 Dec 2020	13F
HHLR ADVISORS, LTD.	13F	Company	0.74%	360,000	$29,329,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.65%	318,030	$25,910,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.56%	274,909	$22,397,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.52%	256,428	$20,891,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.52%	254,034	$20,696,000	—	31 Dec 2020	13F
WMS Partners, LLC	13F	Company	0.51%	250,000	$20,368,000	—	31 Dec 2020	13F
Fairmount Funds Management LLC	13F	Company	0.45%	220,098	$17,931,000	—	31 Dec 2020	13F
Nicholas Investment Partners, LP	13F	Company	0.42%	207,452	$16,901,000	—	31 Dec 2020	13F
Cormorant Asset Management, LP	13F	Company	0.41%	200,000	$16,294,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.36%	177,796	$14,485,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.36%	177,267	$14,442,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.34%	167,182	$13,620,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.31%	150,419	$12,255,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.3%	148,958	$12,136,000	—	31 Dec 2020	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.3%	146,325	$11,921,000	—	31 Dec 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.27%	131,383	$10,704,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	0.24%	115,802	$9,435,000	—	31 Dec 2020	13F
SEI INVESTMENTS CO	13F	Company	0.23%	110,521	$9,004,000	—	31 Dec 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	88,888	$7,242,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.17%	81,300	$6,624,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	0.16%	77,500	$6,314,000	—	31 Dec 2020	13F
CWM, LLC	13F	Company	0.19%	91,417	$6,167,000	—	31 Dec 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.15%	72,254	$5,887,000	—	31 Dec 2020	13F
WCM INVESTMENT MANAGEMENT, LLC	13F	Company	0.15%	72,107	$5,875,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.13%	63,200	$5,149,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	60,357	$4,917,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.11%	53,185	$4,334,000	—	31 Dec 2020	13F
SG Americas Securities, LLC	13F	Company	0.11%	52,231	$4,255,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.1%	48,960	$3,989,000	—	31 Dec 2020	13F
MORGAN JESS S & CO INC	13F	Company	0.09%	44,468	$3,623,000	—	31 Dec 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.09%	43,866	$3,574,000	—	31 Dec 2020	13F
MOODY ALDRICH PARTNERS LLC	13F	Company	0.09%	43,613	$3,553,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.09%	42,000	$3,422,000	—	31 Dec 2020	13F

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q1 2021

As of 31 Mar 2021, Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by 181 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,937,308 shares. The largest 10 holders included VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, ALETHEA CAPITAL MANAGEMENT, LLC, ALLIANCEBERNSTEIN L.P., STATE STREET CORP, BAKER BROS. ADVISORS LP, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 181 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

178

Q1 2021 holders

181

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.